22 November 2017
News and Views
Links and Services
A study in this week's issue of the Journal of the American Medical Association examines the effect of thalidomide on clinical remission in children and adolescents with refractory Crohn disease.
Pediatric-onset Crohn disease is more aggressive than adult-onset disease, has high rates of resi
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors